Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Minimal change disease immunohistology

Introduction

Overview

Overview

A kidney biopsy is not routinely performed as soon as nephrotic syndrome is found during lab work-up. According to the National Kidney Foundation (NKF) Kidney Disease – Improve Global Outcomes (KDIGO) guidelines in 2012, an initial attempt using corticosteroids should be performed before a renal biopsy is performed. A renal biopsy of minimal change disease shows no or minimal abnormalities on light microscopy. Lipid-laden cells may be seen in proximal tubular epithelium. Renal biopsy is often unremarkable under immunofluorescence, with the exception of few cases that stain positively for IgM antibodies and C3.The hallmark of minimal change disease is absence of visible alterations on light microscopy and absence of effacement of foot processes by electron microscopy.

Immunohistology

Immunohistology

Light Microscopy

Immunofluorescence

  • Renal biopsy is often unremarkable under immunofluorescence, with the exception of few cases that stain positively for IgM antibodies and C3.[4]
References

References

  1. ↑ Beck L, Bomback AS, Choi MJ, Holzman LB, Langford C, Mariani LH; et al. (2013). “KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis”. Am J Kidney Dis. 62 (3): 403–41. doi:10.1053/j.ajkd.2013.06.002. PMIDΒ 23871408.
  2. ↑ Vivarelli, Marina; Massella, Laura; Ruggiero, Barbara; Emma, Francesco (2017). “Minimal Change Disease”. Clinical Journal of the American Society of Nephrology. 12 (2): 332–345. doi:10.2215/CJN.05000516. ISSNΒ 1555-9041.
  3. ↑ Vivarelli M, Massella L, Ruggiero B, Emma F (February 2017). “Minimal Change Disease”. Clin J Am Soc Nephrol. 12 (2): 332–345. doi:10.2215/CJN.05000516. PMCΒ 5293332. PMIDΒ 27940460.
  4. ↑ 4.0 4.1 4.2 D’Agati V (2003). “Pathologic classification of focal segmental glomerulosclerosis”. Semin Nephrol. 23 (2): 117–34. doi:10.1053/snep.2003.50012. PMIDΒ 12704572.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]